Phase 1 Single-ascending Dose Study to Evaluate Safety and Tolerability of MEDI4920 in Healthy Adults
Clinical trial NCT02151110 · COMPLETED
Trial details
- NCT number
- NCT02151110
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-27
- Primary completion
- 2016-05-09
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.